Recombinant Cell Culture Supplements Market to be Valued USD 789 Million by 2028
Rising
demand for biologic drugs and advancements in cell culture technologies are
driving the growth of Global Recombinant Cell Culture Market in the forecast
period 2024-2028.
According to TechSci Research report, “Recombinant Cell Culture
Supplements Market – Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028F”, Recombinant Cell
Culture Supplements Market is expected to grow during the forecast period 2024-2028
with a CAGR of 8.99%. This can be ascribed to the growing
demand for biologics drugs and personalized medicine. Advancements in cell
culture technologies, rising prevalence of chronic diseases, and increasing
investment in biopharmaceutical research are also contributing to the growth of
global Recombinant Cell Culture Supplements market in coming years.
Additionally, the increasing use of single-use technologies is also
influencing the growth of Global Recombinant Cell Culture Supplements Market.
Single-use systems are disposable and can be easily integrated into existing
manufacturing processes, offering cost savings and reducing the risk of
contamination. This trend is particularly relevant for biologics manufacturing,
where there is a need for flexibility and efficiency. Companies are
increasingly investing in single-use technologies and customizing recombinant
cell culture supplements to meet specific needs.
The shift towards serum-free cell culture supplements is also
responsible for the growth of Global Recombinant Cell Culture Supplements market
in coming years. Serum-free supplements are free of animal-derived components,
reducing the risk of contamination and improving the consistency of the final
product. With growing concerns about animal welfare and the potential for
disease transmission, many companies are turning to serum-free cell culture
supplements as a safer and more sustainable alternative.
While the recombinant cell culture supplements market is growing
rapidly, there are also several challenges that need to be addressed in order
to sustain this growth. These challenges include the high cost of products, the
lack of standardization in cell culture methods, regulatory requirements, the
potential for contamination, and ethical concerns.
Browse over 151 market data Figures spread through 266 Pages and an in-depth TOC on "Global Recombinant Cell Culture Supplements Market"
Global Recombinant
Cell Culture Supplements Market
can be segmented by product, by application, by expression system, by end user and
by region.
Global Recombinant
Cell Culture Supplements Market can be divided into categories, based on
product: Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant
Albumin, Recombinant Collagen, Recombinant Transferrin, Recombinant Trypsin, and
Others. Recombinant insulin is expected to dominate the recombinant cell
culture supplements market in the forecast years for several reasons. Insulin
is a vital hormone that regulates blood sugar levels in the body, and the
global prevalence of diabetes is increasing rapidly. As a result, the demand
for insulin is expected to rise significantly in the coming years, which will
drive the growth of the recombinant insulin market. The increasing
adoption of insulin pumps and continuous glucose monitoring systems are factors
expected to drive the growth of the recombinant insulin market.
North America, Europe, Asia Pacific, South
America, and Middle East & Africa are the regions into which the global recombinant
cell culture supplement market can be divided. North America is expected to
dominate the recombinant cell culture supplements market in the forecast years because North America has a highly developed healthcare
infrastructure, along with many biopharmaceutical companies, making it a major
market for recombinant cell culture supplements. The region has a significant
presence of major players in the market, which is expected to contribute to the
dominance of North America in the market. The presence of a large number of
academic and research institutions in North America, along with significant
investments in research and development, is expected to drive the growth of the
recombinant cell culture supplements market. These institutions and investments
are contributing to the development of new and innovative cell culture
supplements, which is expected to further increase the demand for recombinant
cell culture supplements in the region.
Major companies operating in Global Recombinant Cell Culture Supplements
Market are:
- Abcam plc.
- Corning Incorporated
- BBI Solutions OEM
Limited
- FUJIFILM Irvine
Scientific, Inc.
- Gemini Bioproducts,
LLC
- HiMedia
Laboratories, LLC
- Kingfisher Biotech,
Inc.
- Lonza Group AG
- Merck KGaA
- Novus Biologicals,
LLC
- ThermoFisher
Scientific
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The recombinant cell culture supplements market is a dynamic and evolving
industry with many opportunities and challenges. The industry is driven by
increasing demand for biologics drugs, the trend towards personalized medicine,
and growing investments in research and development. The growing investments in
research and development in this field are contributing to the development of
innovative cell culture supplements, which is expected to further drive the
growth of the market. However, the
high cost of development, production, and regulatory complexities pose
challenges to the growth of this market.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
Recombinant Cell
Culture Supplements Market- Global Industry Size, Share, Trends, Opportunity
and Forecast, 2018-2028, Segmented By Product (Recombinant Insulin, Recombinant
Epidermal Growth Factors, Recombinant Albumin, Recombinant Collagen,
Recombinant Transferrin, Recombinant Trypsin, Others), By Application {(Regenerative
Medicine (Stem Cell Therapies, Cell Therapies, Gene Therapies) v/sand
Bio-Production(Monoclonal Antibodies, Recombinant Proteins, Hormones, Vaccines,
Others)}), By Expression System (Mammalian Expression System, E. coli
Expression System, Yeast Expression System, Others), By End User (Academic
& Research Institutions, Biotechnology & Pharmaceutical Companies), By
Region and Competition”, has
evaluated the future growth potential of Global Recombinant Cell Culture Supplements
Market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Recombinant Cell Culture
Supplements Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com